Torque's Torcort M40 Injection contains Methylprednisolone, a glucocorticoid used for severe allergic, dermatologic, and rheumatic disorders unresponsive to conventional treatment.
Route of Administration
Intramuscular/Intravenous
Composition
Each vial contains:
- Methylprednisolone Sodium Succinate eq. to Methylprednisolone USP 40 mg
Indications
Indicated for severe allergic, dermatologic, endocrine, gastrointestinal, haematologic, neoplastic, nervous system, ophthalmic, renal, respiratory, and rheumatic disorders unresponsive to conventional treatments, localised inflammatory or hypertrophic lesions (e.g. alopecia areata, keloids, psoriatic plaques, ganglia), and acute and chronic joint or soft tissue inflammatory conditions (e.g. arthritis, bursitis, tenosynovitis).
Storage
Store protected from light and moisture, at a temperature not exceeding 25°C.
Precautions
As directed by the physician. Contraindicated in patients with a known allergy to constituents or excipients, and in premature infants. Can interact with oral anticoagulants, cyclosporine, phenobarbital, phenytoin, rifampin, aspirin, ketoconazole, CYP3A4 inhibitors, CYP3A4 inducers, carbamazepine, neuromuscular blocking agents, antidiabetics, and NSAIDs.
